ES414093A1 - Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria - Google Patents

Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria

Info

Publication number
ES414093A1
ES414093A1 ES414093A ES414093A ES414093A1 ES 414093 A1 ES414093 A1 ES 414093A1 ES 414093 A ES414093 A ES 414093A ES 414093 A ES414093 A ES 414093A ES 414093 A1 ES414093 A1 ES 414093A1
Authority
ES
Spain
Prior art keywords
translation
obtaining
pharmaceutical composition
weight
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES414093A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorex Laboratories Ltd
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Publication of ES414093A1 publication Critical patent/ES414093A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para la obtención de una composición farmacéutica anti-inflamatoria , en forma de dosis unitaria, de peso entre 0,20 y 5, 0 g, preferentemente entren 0,7 y 2,6 g, caracterizado porque comprende las etapas de primeramente mezclar (a) 1-100 mg de ácido glicirretínico y /o al menos un derivado anti-inflamatorio activo del mismo y (b) 1-50% en peso de ácido algínico y/o al menos una sal no tóxica del mismo y/o al menos una carboxialquil-celulosa y/o al menos una sal no-tóxica de la misma; en una segunda etapa mezcla © 1-30% en peso de al menos un carbonato no-toxico y/o bicarbonato y (d) 0-30% en peso de al menos un compuesto antiácido, y en una última etapa hacer reaccionar las mezclas obtenidas en las primeras dos etapas.
ES414093A 1972-12-18 1973-04-26 Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria Expired ES414093A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5835472A GB1390683A (en) 1972-12-18 1972-12-18 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES414093A1 true ES414093A1 (es) 1981-08-16

Family

ID=10481401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES414093A Expired ES414093A1 (es) 1972-12-18 1973-04-26 Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria

Country Status (14)

Country Link
US (1) US3944660A (es)
BE (1) BE802700A (es)
CA (1) CA1006091A (es)
DE (1) DE2360918C3 (es)
ES (1) ES414093A1 (es)
FR (1) FR2210399B1 (es)
GB (1) GB1390683A (es)
HK (1) HK41078A (es)
IE (1) IE38520B1 (es)
IL (1) IL42313A (es)
KE (1) KE2853A (es)
MY (1) MY7800368A (es)
NL (1) NL164472C (es)
ZA (1) ZA732438B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
US4184888A (en) * 1978-03-01 1980-01-22 Dap Inc. Effervescent adhesive-forming product
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
ES8307096A1 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
DE3366910D1 (en) * 1982-04-27 1986-11-20 Noristan Ltd Pharmaceutical compositions and preparation thereof
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
EP0250572A1 (en) * 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
GB2222772B (en) * 1988-09-20 1992-05-13 Glaxo Group Ltd Pharmaceutical compositions
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations
DE102006037298A1 (de) * 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
ITMI20121916A1 (it) * 2012-11-09 2014-05-10 Velleja Res Srl Formulati a cessione intra-gastrica ritardata a base di derivati della glycyrrhiza glabra

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES296176A1 (es) 1964-02-06 1964-05-16 Ferrer Labor Un nuevo compuesto del acido glicirretinico de actividad medicamentosa y su procedimiento de fabricaciën
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3764618A (en) * 1970-10-27 1973-10-09 Dott Inverni & Della Beffa S P Aluminum salts of 3-acetyl-18{62 -glycyrrhetinic acid

Also Published As

Publication number Publication date
AU6312673A (en) 1975-06-05
IL42313A (en) 1976-08-31
IE38520B1 (en) 1978-03-29
CA1006091A (en) 1977-03-01
MY7800368A (en) 1978-12-31
FR2210399B1 (es) 1977-01-28
DE2360918A1 (de) 1974-06-27
IL42313A0 (en) 1973-07-30
DE2360918C3 (de) 1978-07-20
US3944660A (en) 1976-03-16
FR2210399A1 (es) 1974-07-12
DE2360918B2 (de) 1977-11-10
NL164472B (nl) 1980-08-15
ZA732438B (en) 1974-01-30
KE2853A (en) 1978-08-04
HK41078A (en) 1978-07-28
IE38520L (en) 1974-06-18
NL7317238A (es) 1974-06-20
BE802700A (fr) 1974-01-23
GB1390683A (en) 1975-04-16
NL164472C (nl) 1981-01-15

Similar Documents

Publication Publication Date Title
ES414093A1 (es) Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria
NL7506848A (nl) Werkwijze ter bereiding van een farmaceutisch preparaat, alsmede werkwijze ter bereiding van een voor een dergelijk preparaat geschikte fysio- logisch werkzame stof.
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
ES435949A1 (es) Procedimiento de prepracion de acidos 4-aril-4-oxo-2-meti- len-butricos.
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
NL7609463A (nl) Werkwijze voor de bereiding van orale antilipe- mische middelen, alsmede aldus verkregen geneesmiddel.
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
KR830002507A (ko) 옥시테트라사이클린 조성물
JPS51118817A (en) A process for preparing absorbable steroid glycoside pharmaceutical
ES458967A1 (es) Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.
ZA821036B (en) Acesulfam-containing compositions,tablets on the basis thereof and process for the manufacture of these tablets
HU172372B (hu) Insekticidnye kompozicii soderzhahhie zamehhennye proizvodnye oksi-piridina - zamehhennye slozhnom efirom n,n-dialkilaminokarbamidnojj kisloty i sposob poluchenija aktivnykh agentov
NL7500785A (nl) Werkwijze voor de bereiding van nieuwe carbonzu- ren en derivaten daarvan, werkwijze voor de be- reiding van farmaceutische preparaten die deze nieuwe verbindingen bevatten, alsmede farmaceu- tische preparaten verkregen volgens deze werk- wijze.
ES412146A1 (es) Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
IL36286A0 (en) Erythromycylamine compounds,process for the preparation thereof and pharmaceutical compositions containing the same
JPS526071A (en) Mercury emission getter material
GB1327560A (en) Effervescent pharmaceutical preparations
JPS5259186A (en) Preparation of 3-cephem compounds by reduction
NL7416691A (nl) Werkwijze voor de bereiding van 17(alpha)-acyloxy-21- oxypregnanen, alsmede farmaceutische pre- en die deze verbindingen als actieve com- ten omvatten.
IL43727A0 (en) New 2,2-dimethyl steroids,process for their preparation and pharmaceutical compositions
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
ES287586A1 (es) Un procedimiento para la preparación de una composición terapéutica
JPS51136885A (en) New biologically active substance, ml-236a, and its pr eparation